Circulating microparticles, lupus anticoagulant and recurrent miscarriages

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 145, Issue 1, 2009, Pages 22-26

  Alijotas Reig, Jaume ^a   Palacio Garcia, Carles ^a   Vilardell Tarres, Miquel ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Annexin A5; Antiphospholipid antibodies; Cellular microparticles; Endothelial activation; Lupus anticoagulant; Recurrent miscarriages

Indexed keywords

BETA2 GLYCOPROTEIN 1; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; LIPOCORTIN 5; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PROTEIN C; THROMBOPLASTIN; VASCULAR CELL ADHESION MOLECULE 1;

ANTICOAGULATION; APOPTOSIS; CELL ACTIVATION; CELL MEMBRANE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HUMAN; MEMBRANE MICROPARTICLE; PRIORITY JOURNAL; RECURRENT ABORTION; REVIEW; SPONTANEOUS ABORTION; UPREGULATION;

EID: 67649945850     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2009.04.002     Document Type: Review

References (50)

1. Alijotas-Reig J., and Ferrer-Raventos J.C. Recurrent miscarriage and inherited thrombophilia: diagnostic work-out and therapeutic management. Med Clin (Barc) 125 (2005) 626-631
2. Greer I.A. Thrombosis in pregnancy: maternal and fetal issues. Lancet 353 (1999) 1258-1265
3. Coulam C.B. Epidemiology of recurrent spontaneous abortion. Am J Reprod Immunol 26 (1991) 23-27
4. Coulam C.B., Faulk W.P., and McIntyre J.A. Immunotherapy for recurrent spontaneous abortion and its analogies to treatment for cancer. Am J Reprod Immunol 25 (1991) 114-119
5. Taylor R.N., de Groot C., Cho Y.K., and Lim H.K. Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia. Semin Repord Endocrinol 16 (1998) 17-31
6. Meroni P.L. Endothelial cell perturbation by anti-phospholipid antibodies in systemic lupus erythematosus. Lupus 16 Suppl. (2007) 17-19
7. Meroni P.L., Borghi M.O., Raschi E., et al. Inflammatory response and the endothelium. Thromb Res 114 (2004) 329-334
8. Roubay R.A. Tissue factor pathway and the antiphospholipid syndrome. J Autoimmun 15 (2000) 217-220
9. Kaplasnki G., Cacoub P., Farnarier C., et al. Increased soluble vascular cell adhesion molecule 1 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: correlations with severity of thrombosis. Arthritis Rheum 43 (2000) 55-64
10. Meroni P.L., and Riboldi P. Pathogenic mechanisms of antiphospholipid syndrome: a new autoimmune disease. Drug Disc Today: Dis Mech 1 (2004) 309-314
11. Distler J.H., Pisetsky D.S., Huber L., Kalden J.R., Gay S., and Distler O. Microparticles as regulators of inflammation. Arthritis Rheum 52 (2005) 3337-3348
12. Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol 13 (1967) 269-288
13. Germain A.S.J., Sacks G.P., Soorana S., Sargent I.L., and Redman C.W. Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotophoblast microparticles. J Immunol 178 (2007) 5949-5956
14. Hamilton K.K., Hattori R., Esmon C.T., and Sims P.J. Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. J Biol Chem 265 (1990) 3809-3814
15. Hristov M., Erl W., Linder S., and Weber P.C. Apoptotic bodies from endothelial cells enhanced the number and initiate the differentiation of human endothelial progenitor cells in vitro. Blood 104 (2004) 2761-2766
16. Denzer K., van Eijk M., Kleijmeer M.J., Jakobson E., de Groot C., and Geuze H.J. Follicular dendritic cells carry MHC class-II-expressing microvesicles at their surface. J Immunol 165 (2000) 1259-1265
17. Denzer K., Kleijmeer M.J., Heijnen H.F., Stoorvogel W., and Geuze H.J. Exosome: from internal vesicle of the multivesicular body to intercellular signalling device. J Cell Sci 113 (2000) 3365-3374
18. Fourcade O., Simon M.F., Viode C., et al. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 80 (1995) 919-927
19. Brogan P.A., Shah V., Brachet C., et al. Endothelial and platelet microparticles in vascultis of the young. Arthritis Rheum 50 (2004) 927-936
20. Distler J.H., Huber L.C., Reich III C.F., Gay S., Distler O., and Pisetsky D.S. The release of microparticles by apoptoticcells and their effects on macrophages. Apoptosis (2005)
21. Butikofer P., Kuypers F.A., Xu C.M., Chiu D.T., and Lubin B. Enrichment of two glyosyl-phosphatidylinositol-anchored proteins, acetylcholinenesterase and decay accelerating factor, in vesicles released from human red blood cells. Blood 74 (1989) 1481-1485
22. Salzer U., Hinterdorfer P., Hunger P., Borken C., and Prohaska R. Ca(++)-dependent vesicle release from erythrocytes involves stomatin-specific lipid rafts, synexin (annexin VII), and sorcin. Blood 99 (2002) 2569-2577
23. Jy W., Horstman L.L., Jimenez J.J., and Ahn Y.S. Measuring circulating cell-derived microparticles. J Thromb Haemost 2 (2004) 1842-1843
24. Kupferminc M.J., and Eldor A. Inherited thrombophilia and gestational vascular complications. Semin Thromb Haemost 29 (2003) 185-193
25. Infante-Rivard C., David M., Gauthier R., and Rivard G.E. Lupus anticoagulants, anticardiolipin antibodies, and fetal loss: a case-control study. N Engl J Med 325 (1991) 1063-1066
26. Branch W.R., and Khamashta M.A. Antiphospholpid syndrome: obstetric diagnosis, management, and controversies. Obstet Gynecol 101 (2003) 1333-1448
27. Alijotas J. Towards the understanding of heterogeneity of clinical manifestations related to antiphospholipid antibodies. Med Clin (Barc) 125 (2005) 187-189
28. Laude I., Rongieres C., Boyer C., et al. Circulating procoagulant microparticles in women with unexplained pregnancy loss: a new insight. Thromb Haemost 85 (2001) 18-21
29. Bevers E.M., Comfurius P., Dekkers D.W., Harmsma M., and Zwaal R.F. Trnasmembrane phospholipids distribution in blood cells: control mechanism and pathophysiological significance. J Biol Chem 379 (1998) 973-986
30. Barry O.P., Practico D., Lawson J.A., and Fitzgerald G.A. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest 99 (1997) 2118-2127
31. Mesri M., and Altieri D.C. Endothelial cell activation by leukocyte microparticles. J Immunol 16 (1998) 4382-4387
32. Mallat Z., Benamer H., Hugel J.M., et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 101 (2000) 841-848
33. Galli M., Grassi I., and Barbui T. Platelet-derived microvesicles in thrombotic thrombocytopenic purpura and haemolytic uremic syndromes. Thromb Haemost 75 (1996) 427-431
34. Jimenez J.J., Jy W., Mauro L.M., Hortsman L.L., and Ahn Y.S. Elevated endothelial microparticles in thrombotic trombocitopenic purpura: findings from brain and renal mirovascular cell culture and patients with active disease. Br J Haematol 112 (2001) 81-90
35. Joop K., Nieuwland R., Berrckmans R.J., et al. Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanism. Thromb Haemost 85 (2001) 810-820
36. Minagar A., Jimenez J.J., Jy W., et al. Elevated plasma endothelial microparticles in multiple sclerosis. Neurology 56 (2001) 1319-1324
37. Bretelle F., Sabatier F., Desprez D., et al. Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intra uterine growth restriction. Thromb Haemost 89 (2003) 486-492
38. Carp H., Dardik R., Lubetsky A., et al. Prevalence of circulating procoagulant microparticles in women with recurrent miscarriage: a case-controlled study. Hum Reprod 19 (2004) 191-195
39. Combes B., Simon A.C., Grau G.E., et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 104 (1999) 93-102
40. Omatsu K., Kobayashi T., Murakami Y., et al. Phophatidylserine/phosphatidylcholine microvesicles can induce pre-eclampsia-like changes in pregnant mice. Semin Thromb Haemost 31 (2005) 314-320
41. Van Wijk M.J., Svedas E., Boer K., Nieuwland R., Vanbavel E., and Kublickiene K.R. Isolated microparticles, but not whole plasma, from women with preeclampsia impair entothelium-dependent relaxation in isolated myometrial arteries from healthy pregnant women. Am J Obstet Gyneol (2002) 187
42. Greer I.A. Endothelial cell microparticles and antiphospholipid syndrome: pathologic explanations and diagnostic opportunities. Thromb Haemost 91 (2004) 636-638
43. Dignat-George F., Camoin L., Sabatier F., et al. Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome. Thromb Haemost 91 (2004) 667-673
44. D'Cruz D., and Hughes G. Antibodies, thrombosis and the endothelium. Br J Rheumatol 33 (1996) 2-5
45. Galli M., Luciani D., Bertolini G., and Barbui T. Lupus anticoagulants are stronger risk factors of thrombosis than anticardiolipina antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 101 (2003) 1827-1832
46. Beutler B., and Bazzoni F. TNF, apoptosis and autoimmunity a common threat?. Blood Cells Mol Dis 24 (1998) 216-230
47. Chironi G.N., Boulanger C.M., Simon A., Dignat-George F., Freyssenet J.M., and Tedgui A. Endothelial microparticles in disease. Cell Tissue Res 335 (2009) 143-151
48. Jy W., Tiede M., Bidot C.J., Hortsmann L.L., Jiménez J.J., and Chirinos J. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphiospholipid antibodies. Thromb Res 121 (2007) 319-325
49. Pereira J., Alfaro G., Goycoolea M., et al. Circulating platelet-derived microparticles in systemic lupus erythematosus Association with increased thrombin generation and procoagulant state. Thromb Haemost 95 (2006) 94-99
50. Toth B., Niewland R., Kern M., et al. Systemic changes in haemostatic balance are not associated with increased levels of circulating microparticles in women with recurrent spontaneous abortion. Am J Reprod Immunol 59 (2008) 159-166